Skip navigation

Treatment of neurodegenerative conditions

Treatment of neurodegenerative conditions

BTG International Limited (2005) Treatment of neurodegenerative conditions. WO2005/018632/A1.

[img]
Preview
PDF
WO2005018632A1.pdf

Download (3MB)

Abstract

A method is provided for treating a patient in need of therapy for a neurodegenerative disease comprising administering to that patient a therapeutically effective dose of a lipid glyceride comprising a glycerol moiety and a fatty acid moiety, the fatty acid moiety being selected from the group consisting of gamma-linolenic acid, dihomo-gamma-linolenic acid and arachidonic acid characterised in that the selected fatty acid moiety is attached to the glycerol moiety at its sn-2 position. Preferably the method is that wherein the lipid is administered for a duration and at a dose sufficient to maintain or elevate TGF-beta1 levels in the patient to therapeutic levels.

Item Type: Patent
Additional Information: Publication date: Mar 3, 2005 WO_2005_018632_A1 Application date: Aug 13, 2004 GB_2004003524_W
Uncontrolled Keywords: Treatment of multiple sclerosis
Subjects: Q Science > QD Chemistry
R Medicine > RM Therapeutics. Pharmacology
Faculty / Department / Research Group: Faculty of Engineering & Science > Department of Life & Sports Sciences
Related URLs:
Last Modified: 17 Oct 2016 09:10
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: None
URI: http://gala.gre.ac.uk/id/eprint/4330

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics